about
Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosisWhat you always needed to know about electroporation based DNA vaccinesRNA-Based Vaccines in Cancer ImmunotherapyAllergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseasesNucleic acids in circulation: are they harmful to the host?Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccineSynthetic DNA vaccine strategies against persistent viral infectionsLong-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccineSang Froid in a time of trouble: is a vaccine against HIV possible?Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationThe good and evil of complement activation in HIV-1 infectionMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesCytokines as biomarkers of nanoparticle immunotoxicityIntramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cellsSafety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adultsImpact of immunization technology and assay application on antibody performance--a systematic comparative evaluationIn vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersEfficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.Immunogenicity and protective efficacy of recombinant M2e.Hsp70c (Hsp70(359-610)) fusion protein against influenza virus infection in mice.Molecular mechanisms for enhanced DNA vaccine immunogenicity.Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.Interleukin-8 holds promise to serve as a molecular adjuvant in DNA vaccination model against Streptococcus iniae infection in fish.Prospects for control of emerging infectious diseases with plasmid DNA vaccines.An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.Chikungunya: a potentially emerging epidemic?Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles.Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.Gene therapy by electroporation for the treatment of chronic renal failure in companion animalsCharacterization and performance of nucleic acid nanoparticles combined with protamine and gold.Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa InfectionCimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell.Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineVaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
P2860
Q21256673-AA4A1863-0E23-4BD1-BE4E-1B7C18C79D16Q24602340-7035E60D-7914-4096-9411-EDDDBE54394CQ26776028-A90D58DF-B69F-4382-BB0B-E02F91DBC39AQ26828969-C4B5E8AF-2BAC-4C97-A8B4-DC3A6C00E87EQ27011448-9BCB96C0-479E-438F-A14A-3CE67A39CF68Q27013822-A294C450-9F8E-4FFC-83C5-2064A1091696Q27016078-39CEB503-B8E2-48FE-9C09-046E30A29DB3Q27334460-BC6A34C9-2FBB-4FEC-8454-657DA1B3054EQ27487961-FDE5C165-6396-4B80-91AD-0B927960B464Q28236770-223C4E0E-F564-4386-B1EC-D3BDBD6EB53FQ28275986-72790711-4FFC-4A41-A695-891749FD72CDQ28294355-DEB1B960-7EFF-4FD0-8CA4-7F23DD6265DFQ28383550-F8CC14DC-B309-4C2D-96D0-65DCEC5C6729Q28652428-D0D316BD-DEB0-4687-B803-F031EBB0DD79Q28740321-38CEB707-F10A-47C3-897A-59667A1B44BFQ28741074-A2A49794-4A8B-4ADC-A6F7-2B4B9D88C525Q28744555-7391E025-3E8D-4E00-9172-A35CB876D913Q30204348-8F15745A-957C-44C4-92E5-DE540ACBDDFDQ30352934-1D7CE983-8CED-474A-B84A-0397B91496F9Q30366089-F1027285-72D0-46E3-9B10-85BB6B3D7EB6Q30366743-F1373283-DD1B-4C3E-8BEB-845D6FC5623AQ30372481-58BCF4B2-124D-4F60-AD93-DAF61C8743B8Q30376672-B8A76D1D-D210-4E6F-8659-3640F7B5832AQ30377442-EC4CCD9E-1B28-4117-B18D-B7C9EDA8DBA7Q30380454-AA0BAF54-3287-47F1-8BD0-4CE0459BB1D3Q30384563-A2CBCFCB-30D3-478F-890A-026179B44316Q30388754-B634D4BF-654E-427A-B5F7-B305D6FA8D13Q30397107-171B24A2-6EC2-4223-ABA6-664BFFC6D139Q30415387-10ECCC50-5613-4633-8EB7-6E2C9CAA3E3EQ30418340-50CE3158-4E93-4D41-BE87-4E1312A8601BQ30430152-BB7AC6EA-AD39-4232-9465-CF33362113DAQ33400571-299E32BA-AB46-4CD8-BCCB-7739BC0D81D8Q33499568-D600A6DF-9D1F-4BDC-8D21-1A30E691E7BCQ33507532-F11B828F-BFC3-4493-87DB-E0F110245190Q33553646-CB0745E0-769C-44C5-8D5F-CEACD5DC7336Q33578026-FBCB0B4C-7CDC-4133-9BA9-F80273F38FABQ33586294-810BA8E7-ACC2-420C-AB48-6CCBCDF84248Q33604583-B06BB1F4-E488-4B93-BBDD-54B07308A953Q33614476-94FE58AA-9C5B-4B25-A47C-B246F4BC0D82Q33617793-41C3E182-67ED-4AC3-8627-DD356C108E55
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
DNA vaccines: ready for prime time?
@ast
DNA vaccines: ready for prime time?
@en
DNA vaccines: ready for prime time?
@nl
type
label
DNA vaccines: ready for prime time?
@ast
DNA vaccines: ready for prime time?
@en
DNA vaccines: ready for prime time?
@nl
prefLabel
DNA vaccines: ready for prime time?
@ast
DNA vaccines: ready for prime time?
@en
DNA vaccines: ready for prime time?
@nl
P2860
P356
P1476
DNA vaccines: ready for prime time?
@en
P2093
David B Weiner
Michele A Kutzler
P2860
P2888
P304
P356
10.1038/NRG2432
P577
2008-10-01T00:00:00Z
P5875
P6179
1045591023